Argan (AGX) vs Exponent (EXPO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 11, 2026.
Summary
Argan (AGX) has outperformed Exponent (EXPO) over the past year, gaining 53.3% versus a gain of 7.0%. Over five years, AGX leads with a +785.1% price change compared with -37.1% for EXPO. Argan is the larger company by market cap ($5.51 billion vs $3.32 billion), about 1.7 times the size.
On valuation, Argan trades at a lower forward P/E (24.4x vs 25.7x for Exponent). Exponent offers the higher dividend yield (1.75% vs 0.51%). Exponent converts more of its revenue into profit, with a net margin of 18.2% versus 14.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AGX | EXPO |
|---|---|---|
| Share price | $392.61 | $69.81 |
| Market cap | $5.51B | $3.32B |
| 1-day change | -1.52% | +0.04% |
| YTD return | +25.31% | +0.50% |
| 1-year return | +53.27% | +6.96% |
| 5-year return | +785.05% | -37.06% |
| P/E ratio (TTM) | 31.04 | 31.30 |
| Forward P/E | 24.37 | 25.66 |
| EPS (TTM) | $12.65 | $2.23 |
| Dividend yield | 0.51% | 1.75% |
| Annual dividend | $2.00 | $1.22 |
| Revenue (latest FY) | $944.61M | $582.01M |
| Revenue growth (YoY) | +8.06% | +4.21% |
| Net income (latest FY) | $137.77M | $106.01M |
| Gross margin | 20.50% | — |
| Operating margin | 14.26% | 20.58% |
| Net margin | 14.59% | 18.21% |
| 52-week high | $805.75 | $81.95 |
| 52-week low | $257.62 | $51.91 |
| Distance from 52-week high | -51.27% | -14.81% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +45.31% | +20.33% |
| Average volume | 361.26K | 516.69K |
| Shares outstanding | 14.03M | 47.55M |
| Employees | 1,409 | 1,012 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Engineering & Construction | Professional Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AGX has outperformed EXPO by 46.3 percentage points over the past year.
- Exponent offers a meaningfully higher dividend yield (1.75% vs 0.51%).
About Argan
AGX stock →Argan, Inc., through its subsidiaries, provides engineering, procurement, construction, commissioning, maintenance, project development, and technical consulting services to the power generation market in the United States, Republic of Ireland, and the United Kingdom. It operates through three segments: Power, Industrial, and Teledata.
Consumer Discretionary · Engineering & Construction · 1,409 employees
About Exponent
EXPO stock →Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health.
Consumer Discretionary · Professional Services · 1,012 employees
AGX vs EXPO FAQ
Which is bigger, Argan or Exponent?
Argan (AGX) is larger, with a market capitalization of $5.51B compared with $3.32B for Exponent (EXPO).
Which stock has performed better over the past year, AGX or EXPO?
AGX returned +53.27% over the past 12 months, compared with +6.96% for EXPO (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, AGX or EXPO?
AGX has the lower trailing P/E at 31.0, versus 31.3 for EXPO. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Argan or Exponent?
Exponent has the higher yield at 1.75%, compared with 0.51% for Argan.
Are Argan and Exponent in the same industry?
Both are in the Consumer Discretionary sector, but in different industries: Engineering & Construction for Argan and Professional Services for Exponent.